<- Go home

Added to YB: 2024-09-23

Pitch date: 2024-09-23

XGN:US [bullish]

Exagen Inc.

+128.62%

current return

Author Info

No bio for this author

Company Info

Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States.

Market Cap

$204.2M

Pitch Price

$3.11

Price Target

N/A

Dividend

N/A

EV/EBITDA

-21.18

P/E

-9.59

EV/Sales

3.09

Sector

Biotechnology

Category

N/A

Show full summary:
Exagen, Inc. XGN:US

A summary for this pitch has not been created yet.

Read full article (0 min)